On April 27, the U.S. Food and Drug Administration approved Levaquin (levofloxacin) to treat patients with plague. The drug was approved under the agency’s…
A study of hospital-acquired infections (HAIs) in the ICU presented at the 22nd European Congress of Clinical Microbiology and Infectious Diseases found that inpatient…
One of The Joint Commission’s 2012 National Patient Safety Goals is preventing urinary tract infections caused by catheters. The author reviews best practices that…
On Feb. 7, the U.S. Food and Drug Administration announced that drug interactions between the hepatitis C virus protease inhibitor Victrelis (boceprevir) and certain…
A study of hospital-acquired infections (HAIs) in the ICU presented at the 22nd European Congress of Clinical Microbiology and Infectious Diseases found…
On Feb. 7, the U.S. Food and Drug Administration announced that drug interactions between the hepatitis C virus protease inhibitor Victrelis (boceprevir)…